Skip to content

Opening book details…

About this Medicine article

Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort by Barata, Pedro; Hatton, Whitley; Desai, Arpita; Koshkin, Vadim; Jaeger, Ellen; Manogue, Charlotte; Cotogno, Patrick; Light, Malcolm; Lewis, Brian; Layton, Jodi; Sartor, Oliver; Basu, Arnab; Kilari, Deepak; Emamekhoo, Hamid; Bilen, Mehmet A. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Barata, Pedro; Hatton, Whitley; Desai, Arpita; Koshkin, Vadim; Jaeger, Ellen; Manogue, Charlotte; Cotogno, Patrick; Light, Malcolm; Lewis, Brian; Layton, Jodi; Sartor, Oliver; Basu, Arnab; Kilari, Deepak; Emamekhoo, Hamid; Bilen, Mehmet A.
Publisher
Frontiers Media SA; Frontiers Media S.A.; Lausanne: Frontiers Media S.A., 2011- (ISSN 2234-943X)
Published
2020
Field
Medicine (Health Sciences)

More by Barata, Pedro; Hatton, Whitley; Desai, Arpita; Koshkin, Vadim; Jaeger, Ellen; Manogue, Charlotte; Cotogno, Patrick; Light, Malcolm; Lewis, Brian; Layton, Jodi; Sartor, Oliver; Basu, Arnab; Kilari, Deepak; Emamekhoo, Hamid; Bilen, Mehmet A.

Browse all works by Barata, Pedro; Hatton, Whitley; Desai, Arpita; Koshkin, Vadim; Jaeger, Ellen; Manogue, Charlotte; Cotogno, Patrick; Light, Malcolm; Lewis, Brian; Layton, Jodi; Sartor, Oliver; Basu, Arnab; Kilari, Deepak; Emamekhoo, Hamid; Bilen, Mehmet A.